ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (1082)	3/8/2000 8:50:00 AM
From: scott_jiminez	Read Replies (1) of 4474

I meant to include Cambridge Neuroscience (CNSI) in my list stocks receiving my former Ariad funds. I like what they're doing with Glial Growth factors for brain injuries and myelin related diseases (i.e. multiple sclerosis). As I said earlier, I also like the clear respect for their research (based on their publication record). Most importantly, CNSI's association with Cedric Raine is a huge positive factor. Not only is he probably the most widely known researcher in myelin related diseases, he is also the editor of the Journal of Neuroimmunology and is thus exposed to 'the heartbeat' of relevant research. He may also be in a position to help catalyze clinical trials for CNSI. I will be posting more info on the CNSI thread.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next